Trade

Syngene International share price

Balanced risk
  • 38%Low risk
  • 38%Moderate risk
  • 38%Balanced risk
  • 38%High risk
  • 38%Extreme risk
  • ₹471.00(1.61%)
    May 14, 2026 15:29:57 PM IST
    • NSE
    • BSE
  • Vol : 1.51 M (NSE + BSE)
    Last 20 day avg : 4.96 M

Syngene International is trading 1.61% upper at Rs 471.00 as compared to its last closing price. Syngene International has been trading in the price range of 485.00 & 465.00. Syngene International has given -28.84% in this year & 2.92% in the last 5 days. There are 8 analysts who have initiated coverage on Syngene International. There are 1 analysts who have given it a strong buy rating & 4 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 147.90 Crores in its last quarter.Listed peers of Syngene International include Dr Reddy's Laboratories (2.98%), Cipla (8.05%), Torrent Pharmaceuticals (2.85%).The Mutual Fund holding in Syngene International was at 24.18% in 31 Mar 2026. The MF holding has increased from the last quarter. The FII holding in Syngene International was at 13.91% in 31 Mar 2026. The FII holding has decreased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on May 14, 2026, 11:07 AM UTC

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    1.02
    Medium volatility
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.26
    Lower than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    3.97
    Lower than historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    60.91
    Higher than historical values
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -5.12
    Indicates undervaluation
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    -
Price range
Day Range
Lowest
465.00
Highest
485.00
52 week range
Lowest
380.00
Highest
728.40
Syngene International News
Syngene International Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Dr Reddy's Laboratories
Bullish
1,302.802.981,08,734.0218.633.140.632.34
Cipla
Moderately Bullish
1,434.008.051,15,557.4022.953.870.870.81
Torrent Pharmaceuticals
Bullish
4,417.652.851,48,470.3467.3217.10.8317.62
Sun Pharmaceutical Industries
Bullish
1,863.002.124,46,985.5736.245.770.920.50
Divi's Laboratories
Bullish
6,947.002.281,84,317.9078.6111.520.460.01
Mutual Fund Ownership
View all
LIC MF Healthcare Fund Regular Growth
NA
  • Amount Invested (Cr.) 2.55
  • % of AUM 3.02
Mirae Asset Focused Fund Regular Growth
2/5
  • Amount Invested (Cr.) 223.16
  • % of AUM 2.82
DSP Multicap Fund Regular Growth
NA
  • Amount Invested (Cr.) 57.65
  • % of AUM 2.55
DSP Focused Fund Growth
3/5
  • Amount Invested (Cr.) 63.83
  • % of AUM 2.48
Nippon India Innovation Fund Regular Growth
NA
  • Amount Invested (Cr.) 63.40
  • % of AUM 2.47
Syngene International Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2026-04-29Audited Results & Final Dividend
2026-01-22Quarterly Results
2025-11-05Quarterly Results
2025-07-23Quarterly Results
2025-04-23Audited Results & Final Dividend
About the company Syngene International
  • IndustryBiotechnology & Drugs
  • ISININE398R01022
  • BSE Code539268
  • NSE CodeSYNGENE
Syngene International Limited is an India-based integrated research, development, and manufacturing services company serving the global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors. The Company's services include discovery, development, manufacturing, SynVent Integrated Drug discovery, dedicated centers, and Center for Advanced Protein Studies (CAPS). Its discovery services span the entire spectrum of early-stage research from target identification to delivery of drug candidates for further development. It offers preclinical development, active pharmaceutical ingredient and drug product development for both small molecules and biologics. It has capabilities for current Good Manufacturing Practices (cGMP) manufacturing from benchtop volume to commercial scale. SynVent is its drug discovery platform for enabling fully integrated therapeutic drug discovery and development across small molecules, new modalities and biologics.
  • Management Info
  • Peter BainsChief Executive Officer, Managing Director, Additional Director
  • Deepak JainChief Financial Officer
  • Andrew WebsterChief Human Resources Officer
  • Kenneth BarrSenior Vice President - Research Services
  • Alex Del PrioreSenior Vice President - Manufacturing Services
  • Gaurav KushwahaChief Technology Officer
  • Jayashree AiyarChief Scientific Officer
  • Chethan YogeshCompliance Officer, Company Secretary
  • Pramuch GoelHead of Corporate Affairs
  • Caroline HempsteadHead of Customer Centricity and Special Projects
Syngene International Share Price FAQs

Syngene International is trading at 471.00 as on Thu May 14 2026 09:59:57. This is 1.61% upper as compared to its previous closing price of 463.55.

The market capitalization of Syngene International is 18919.27 Cr as on Thu May 14 2026 09:59:57.

The average broker rating on Syngene International is Buy. The breakup of analyst rating is given below -

  • 1 analysts have given a strong buy rating
  • 4 analysts have given a buy rating
  • 2 analysts have given a hold rating
  • 0.00 analysts have given a sell rating
  • 1 analysts have given a strong sell rating

The 52 wk high for Syngene International is 728.40 whereas the 52 wk low is 380.00

Syngene International can be analyzed on the following key metrics -

  • TTM P/E: 49.48
  • Sector P/E: -
  • Dividend Yield: 0.27%
  • D/E ratio: 0.09

Syngene International reported a net profit of 316.70 Cr in 2026.

The Mutual Fund Shareholding was 24.18% at the end of 31 Mar 2026.

Quick Links
EQUITY QUICK LINKS
Syngene International QUICK LINKS
FROM MARKETS
RELATED LINKS
Quarterly Results
Home/Market/Market Stats/  Syngene International share price
✕

Wait for it…

Log in to our website to save your bookmarks. It'll just take a moment.

✕

Wait for it…

Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.